Mass Medicines Overview

  • Status
  • Private

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $152M

  • Investors
  • 1

Mass Medicines General Information

Description

Developer of antibody-peptide conjugates (APCs) designed for chronic obesity and metabolic disorders. The company is currently operating in Stealth mode.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • San Francisco, CA
  • United States
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Corporate Office
  • San Francisco, CA
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Mass Medicines Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A) 24-Apr-2026 $152M Completed Stealth
1. Seed Round Completed
To view Mass Medicines’s complete valuation and funding history, request access »

Mass Medicines Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
Seed
To view Mass Medicines’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Mass Medicines Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
venBio Venture Capital Minority
To view Mass Medicines’s complete investors history, request access »

Mass Medicines FAQs

  • Where is Mass Medicines headquartered?

    Mass Medicines is headquartered in San Francisco, CA.

  • What industry is Mass Medicines in?

    Mass Medicines’s primary industry is Drug Discovery.

  • Is Mass Medicines a private or public company?

    Mass Medicines is a Private company.

  • What is the current valuation of Mass Medicines?

    The current valuation of Mass Medicines is .

  • What is Mass Medicines’s current revenue?

    The current revenue for Mass Medicines is .

  • How much funding has Mass Medicines raised over time?

    Mass Medicines has raised $168M.

  • Who are Mass Medicines’s investors?

    venBio has invested in Mass Medicines.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process